Tag: Lecanemab
Filter by:
FDA Grants Accelerated Approval For Alzheimer’s ...
Launched in 2009, the rationale for the RMS® Longevity Risk Model was to bring state-of-the-art developments in the science of aging to the…
Log In
Access all customer product support, event response, and training in one place
LifeRisks PortalFind modeling tools based on best practice actuarial techniques and medical science
Miu PortalExplore analytics and risk insights for the alternative capital market
Insurance Solutions
Formerly Moody’s RMS
Filter by:
Launched in 2009, the rationale for the RMS® Longevity Risk Model was to bring state-of-the-art developments in the science of aging to the…